Literature DB >> 33831743

Post-sprain versus post-fracture post-traumatic ankle osteoarthritis: Impact on foot and ankle kinematics and kinetics.

Paul-André Deleu1, Thibaut Leemrijse2, Laurence Chèze3, Alexandre Naaim4, Raphaël Dumas5, Bernhard Devos Bevernage6, Ivan Birch7, Jean-Luc Besse8.   

Abstract

BACKGROUND: Common etiologies for post-traumatic ankle osteoarthritis are ankle fractures and chronic ankle instability. As the nature of trauma is different for these two etiologies, it might be expected that the two subtypes of post-traumatic ankle osteoarthritis would display different foot mechanics during gait. RESEARCH QUESTION: The objective of this exploratory cross-sectional study was to compare the foot kinematics and kinetics of patients suffering from post-fracture ankle osteoarthritis with those of patients suffering from post-sprain ankle osteoarthritis.
METHODS: Twenty-nine subjects with end-stage post-traumatic ankle osteoarthritis and fifteen asymptomatic control subjects participated in this study. All patients suffered from post-traumatic ankle osteoarthritis secondary to ankle-related fracture (Group 1; n = 15) or to chronic ankle instability (Group 2; n = 14). A four-segment kinematic and kinetic foot model was used to calculate intrinsic foot joint kinematics and kinetics during gait. Vector field statistical analysis MANOVA was used to assess differences between groups for the entire three-component intrinsic foot joint angles and moments.
RESULTS: MANOVA showed significant differences between the groups. Post-hoc analyses suggested that the differences between post-fracture ankle osteoarthritis group and controls were caused by a combination of less adducted Shank-Calcaneus position and less plantarflexion at this joint. Post-hoc analyses also suggested that both pathological groups exhibited a decreased plantarflexion moment for Shank-Calcaneus, Chopart, Lisfranc joints compared to controls. Analyses of both pathological groups versus controls for power suggested lower Shank-Calcaneus and Lisfranc power generation during pre-swing phase. SIGNIFICANCE: No significant differences were found between the two pathological groups in this exploratory study. Alterations in foot kinematics and kinetics were mainly found about the dorsi-/plantarflexion axis during the pre-swing phase of the stance phase for both pathological groups compared to controls. Observed differences were not limited to the painful ankle joint, but seem also to have affected the kinetics of the neighbouring foot joints.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ankle; Gait; Intrinsic foot joints; Kinematics; Kinetics; Osteoarthritis

Year:  2021        PMID: 33831743     DOI: 10.1016/j.gaitpost.2021.03.029

Source DB:  PubMed          Journal:  Gait Posture        ISSN: 0966-6362            Impact factor:   2.840


  4 in total

1.  [Comparison of short-term effectiveness of metal screws and absorbable screws in repair of distal tibiofibular syndesmosis].

Authors:  Xinwei Yuan; Bin Zhang; Jiang Hu; Bing Lu
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2022-08-15

2.  The Amsterdam Foot Model: a clinically informed multi-segment foot model developed to minimize measurement errors in foot kinematics.

Authors:  Marjolein M van der Krogt; Jaap Harlaar; Wouter Schallig; Josien C van den Noort; Marjolein Piening; Geert J Streekstra; Mario Maas
Journal:  J Foot Ankle Res       Date:  2022-06-07       Impact factor: 3.050

3.  Short-term results of gait analysis with the Heidelberg foot measurement method and functional outcome after operative treatment of ankle fractures.

Authors:  Jessica C Böpple; Michael Tanner; Sarah Campos; Christian Fischer; Sebastian Müller; Sebastian I Wolf; Julian Doll
Journal:  J Foot Ankle Res       Date:  2022-01-08       Impact factor: 2.303

4.  The Efficacy of Targeted Perioperative Management for Diabetic Patients with Traumatic Calcaneal Fractures.

Authors:  Sibin Hao; Yunpeng Liu; Mingtai Yu; Fang Sun; Dezhang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-28       Impact factor: 2.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.